Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.91% Nasdaq Up0.87%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM

7.66 Up 0.10(1.32%) 4:00PM EDT|After Hours : 7.66 0.00 (0.00%) 4:31PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 7,000   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit 7,000   -   -   -  
Operating Expenses
Research Development6,239  4,753  3,768  3,726  
Selling General and Administrative2,919  1,925  1,758  1,973  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (2,158) (6,678) (5,526) (5,699)
Income from Continuing Operations
Total Other Income/Expenses Net103  50  51  4,195  
Earnings Before Interest And Taxes(2,055)(6,628)(5,475)(4,143)
Interest Expense -   -   -   -  
Income Before Tax(2,055)(6,628)(5,475)(4,143)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(2,055)(9,267)(5,475)(1,504)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (2,055) (6,628) (5,475) (1,504)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (2,055) (6,628) (5,475) (1,504)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.